Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Nov;66(5):930–936. doi: 10.1038/bjc.1992.388

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

A G van der Zee 1, B van Ommen 1, C Meijer 1, H Hollema 1, P J van Bladeren 1, E G de Vries 1
PMCID: PMC1978003  PMID: 1419639

Abstract

Glutathione S-transferase (GST) isoenzyme composition, isoenzyme quantities and enzymatic activity were investigated in benign (n = 4) ovarian tumours and malignant ovarian tumours, before (n = 20) and after (n = 16) chemotherapy. Enzymatic activity of GST in cytosols was measured by determining 1-chloro-2,4-dinitrobenzene conjugation with glutathione, cytosolic GST subunits were determined by wide pore reversed phase HPLC, using a S-hexylglutathione-agarose affinity column, and isoelectric focussing. Both GST activity and GST pi amount were not related to histopathologic type, differentiation grade, or tumour volume index in untreated malignant tumours. GST isoenzyme patterns were identical in benign tumours and malignant tumours before and after platinum/cyclophosphamide chemotherapy, while GST pi was the predominant transferase. Mean GST activity and GST pi amount were decreased (P < 0.05) in malignant ovarian tumours after platinum/cyclophosphamide chemotherapy compared to untreated ovarian malignant tumours. No relation was found in untreated ovarian tumours between GST pi amount and response to platinum/cyclophosphamide chemotherapy. Thus, within the limitations of the current study no arguments were found for a role of GST in in vivo drug resistance of malignant ovarian tumours to platinum/cyclophosphamide chemotherapy.

Full text

PDF
933

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali-Osman F., Stein D. E., Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res. 1990 Nov 1;50(21):6976–6980. [PubMed] [Google Scholar]
  2. Andrews P. A., Howell S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells. 1990 Feb;2(2):35–43. [PubMed] [Google Scholar]
  3. Baak J. P., Schipper N. W., Wisse-Brekelmans E. C., Ceelen T., Bosman F. T., van Geuns H., Wils J. The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients. Br J Cancer. 1988 May;57(5):503–508. doi: 10.1038/bjc.1988.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bogaards J. J., van Ommen B., van Bladeren P. J. An improved method for the separation and quantification of glutathione S-transferase subunits in rat tissue using high-performance liquid chromatography. J Chromatogr. 1989 Jul 19;474(2):435–440. doi: 10.1016/s0021-9673(01)93940-8. [DOI] [PubMed] [Google Scholar]
  5. Boyer T. D. The glutathione S-transferases: an update. Hepatology. 1989 Mar;9(3):486–496. doi: 10.1002/hep.1840090324. [DOI] [PubMed] [Google Scholar]
  6. Carmichael J., Forrester L. M., Lewis A. D., Hayes J. D., Hayes P. C., Wolf C. R. Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis. 1988 Sep;9(9):1617–1621. doi: 10.1093/carcin/9.9.1617. [DOI] [PubMed] [Google Scholar]
  7. Di Ilio C., Del Boccio G., Aceto A., Casaccia R., Mucilli F., Federici G. Elevation of glutathione transferase activity in human lung tumor. Carcinogenesis. 1988 Feb;9(2):335–340. doi: 10.1093/carcin/9.2.335. [DOI] [PubMed] [Google Scholar]
  8. Djuric Z., Malviya V. K., Deppe G., Malone J. M., Jr, McGunagle D. L., Heilbrun L. K., Reading B. A., Lawrence W. D. Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapy. J Cancer Res Clin Oncol. 1990;116(4):379–383. doi: 10.1007/BF01612921. [DOI] [PubMed] [Google Scholar]
  9. Ford J. M., Hait W. N., Matlin S. A., Benz C. C. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Lett. 1991 Jan;56(1):85–94. doi: 10.1016/0304-3835(91)90198-q. [DOI] [PubMed] [Google Scholar]
  10. Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974 Nov 25;249(22):7130–7139. [PubMed] [Google Scholar]
  11. Howie A. F., Forrester L. M., Glancey M. J., Schlager J. J., Powis G., Beckett G. J., Hayes J. D., Wolf C. R. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis. 1990 Mar;11(3):451–458. doi: 10.1093/carcin/11.3.451. [DOI] [PubMed] [Google Scholar]
  12. Keith W. N., Stallard S., Brown R. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer. 1990 May;61(5):712–716. doi: 10.1038/bjc.1990.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kim R., Hirabayashi N., Nishiyama M., Saeki S., Toge T., Okada K. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin. Anticancer Res. 1991 Jan-Feb;11(1):429–431. [PubMed] [Google Scholar]
  14. Lewis A. D., Forrester L. M., Hayes J. D., Wareing C. J., Carmichael J., Harris A. L., Mooghen M., Wolf C. R. Glutathione S-transferase isoenzymes in human tumours and tumour derived cell lines. Br J Cancer. 1989 Sep;60(3):327–331. doi: 10.1038/bjc.1989.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lewis A. D., Hayes J. D., Wolf C. R. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis. 1988 Jul;9(7):1283–1287. doi: 10.1093/carcin/9.7.1283. [DOI] [PubMed] [Google Scholar]
  16. Leyland-Jones B. R., Townsend A. J., Tu C. P., Cowan K. H., Goldsmith M. E. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Res. 1991 Jan 15;51(2):587–594. [PubMed] [Google Scholar]
  17. Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M. K., Warholm M., Jörnvall H. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7202–7206. doi: 10.1073/pnas.82.21.7202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mannervik B., Danielson U. H. Glutathione transferases--structure and catalytic activity. CRC Crit Rev Biochem. 1988;23(3):283–337. doi: 10.3109/10409238809088226. [DOI] [PubMed] [Google Scholar]
  19. Meijer C., Mulder N. H., Hospers G. A., Uges D. R., de Vries E. G. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer. 1990 Jul;62(1):72–77. doi: 10.1038/bjc.1990.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meijer C., Mulder N. H., de Vries E. G. The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treat Rev. 1990 Dec;17(4):389–407. doi: 10.1016/0305-7372(90)90081-p. [DOI] [PubMed] [Google Scholar]
  21. Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Cossman J., Myers C. E., Cowan K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15;49(6):1422–1428. [PubMed] [Google Scholar]
  22. Moscow J. A., Townsend A. J., Cowan K. H. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol Pharmacol. 1989 Jul;36(1):22–28. [PubMed] [Google Scholar]
  23. Ogura K., Nishiyama T., Okada T., Kajital J., Narihata H., Watabe T., Hiratsuka A., Watabe T. Molecular cloning and amino acid sequencing of rat liver class theta glutathione S-transferase Yrs-Yrs inactivating reactive sulfate esters of carcinogenic arylmethanols. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1294–1300. doi: 10.1016/0006-291x(91)92079-y. [DOI] [PubMed] [Google Scholar]
  24. Ozols R. F., Young R. C. Chemotherapy of ovarian cancer. Semin Oncol. 1991 Jun;18(3):222–232. [PubMed] [Google Scholar]
  25. Piver M. S., Baker T. R., Piedmonte M., Sandecki A. M. Epidemiology and etiology of ovarian cancer. Semin Oncol. 1991 Jun;18(3):177–185. [PubMed] [Google Scholar]
  26. Shea T. C., Claflin G., Comstock K. E., Sanderson B. J., Burstein N. A., Keenan E. J., Mannervik B., Henner W. D. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res. 1990 Nov 1;50(21):6848–6853. [PubMed] [Google Scholar]
  27. Shea T. C., Kelley S. L., Henner W. D. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res. 1988 Feb 1;48(3):527–533. [PubMed] [Google Scholar]
  28. Teicher B. A., Holden S. A., Herman T. S., Sotomayor E. A., Khandekar V., Rosbe K. W., Brann T. W., Korbut T. T., Frei E., 3rd Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II). Int J Cancer. 1991 Jan 21;47(2):252–260. doi: 10.1002/ijc.2910470214. [DOI] [PubMed] [Google Scholar]
  29. Terrier P., Townsend A. J., Coindre J. M., Triche T. J., Cowan K. H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol. 1990 Oct;137(4):845–853. [PMC free article] [PubMed] [Google Scholar]
  30. Waxman D. J. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. Cancer Res. 1990 Oct 15;50(20):6449–6454. [PubMed] [Google Scholar]
  31. van Ommen B., Bogaards J. J., Peters W. H., Blaauboer B., van Bladeren P. J. Quantification of human hepatic glutathione S-transferases. Biochem J. 1990 Aug 1;269(3):609–613. doi: 10.1042/bj2690609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van der Zee A. G., Hollema H., de Jong S., Boonstra H., Gouw A., Willemse P. H., Zijlstra J. G., de Vries E. G. P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. Cancer Res. 1991 Nov 1;51(21):5915–5920. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES